Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica

2013138 citationsletterbronze Open Access

Authors

Chun‐Sheng Yang · St. Joseph's Hospital and Medical Center

Li Yang · St. Joseph's Hospital and Medical Center

Ting Li · St. Joseph's Hospital and Medical Center

Daqi Zhang · St. Joseph's Hospital and Medical Center

Wei‐Na Jin · St. Joseph's Hospital and Medical Center

Minshu Li · St. Joseph's Hospital and Medical Center

Ning Su

Abstract

A lower dosage of rituximab may be sufficient in depleting B cells, maintaining low B-cell counts, and preventing disease progression in Chinese patients with NMO.

Topics & Keywords

Multiple Sclerosis Research Studies Polyomavirus and related diseases Acute Lymphoblastic Leukemia research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Neurology

Volume 81, Issue 8, pp. 710-713

DOI: 10.1212/wnl.0b013e3182a1aac7

Field-Weighted Citation Impact: 7.05